Csenge Advisory Group’s Tenet Healthcare THC Stock Holding History

Csenge Advisory Group’s Portfolio THC Stock Details THC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-21	Closed	–	–	1353
2018 Q3	$0	Buy	+21	New	+$693	﹤0.01%	1587

Other funds holding THC

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Csenge Advisory Group's THC Position: Q4 2018 in Review

Csenge Advisory Group sold out of Tenet Healthcare (THC) in Q4 2018, closing a stake of 21 shares.

Csenge Advisory Group first reported a position in THC in Q3 2018 and held it in 1 quarter. The position peaked at $0 in Q3 2018. 263 funds tracked by Wall St. Rank hold THC as of Q4 2018.

Csenge Advisory Group reported no remaining Tenet Healthcare position as of Q4 2018 after selling out during the quarter.
Csenge Advisory Group sold 21 Tenet Healthcare shares in Q4 2018.
Csenge Advisory Group first reported a position in Tenet Healthcare in Q3 2018 and held it in 1 quarter.
Csenge Advisory Group's Tenet Healthcare position peaked at $0 in Q3 2018.
263 funds tracked by Wall St. Rank held Tenet Healthcare as of Q4 2018.

Based on Csenge Advisory Group's 13F filing for Q4 2018, filed 7 Feb 2019.